Tara E. Parks-Crawford
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non-transformed skeletal muscle cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 30, 2021
Distinct roles for the RNA-binding protein Staufen1 in prostate cancer.
Journal: BMC cancer
Published: August 03, 2020
Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.
Journal: Human molecular genetics
Published: January 28, 2020
Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.
Journal: Human molecular genetics
Published: February 13, 2017
Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.
Journal: Scientific reports
Published: September 08, 2016
Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I.
Journal: Rare diseases (Austin, Tex.)
Published: May 18, 2016
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
Journal: PLoS genetics
Published: August 24, 2015
Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.
Journal: Molecular biology of the cell
Published: June 11, 2015
Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.
Journal: Human molecular genetics
Published: June 02, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026